Quetiapine and risperdal in the treatment of schizophrenia:an one-year follow up study.

WANG Huifang,ZHANG Hongxia,YANG Xiaomin,JIANG Kaida

DOI: https://doi.org/10.3969/j.issn.1002-0152.2009.02.003

2009-01-01

Abstract:Objective To study the efficacy and adverse effects of quetiapine and risperdal in the long-term treatment of patients with first-episode schizophrenia.Methods This was an open-label case-control study.Two hundred sixty two patients with first-episode schizophrenia met the diagnostic criteria of ICD-10 were recruited.Patients were randomly divided into two groups with 131 patients in each group which received either quetiapine or risperdal for 12 months.The rate of all-cause treatment discontinuation and time to discountinuation and the rate of reduction in Positive and Negative Syndrome Scale(PANSS) was evaluated.The rate of reduction in PANSS score≥50% was defined as much imporved,<50% and ≥25% was improved,and <25% was no change.Treatment Emergent Symptom Scale(TESS),Rating Scale for Extrapyramidal Side Effects(RSESE) and Abnormal Involuntary Movement Scale(AIMS) were performed to evaluate adverse effects.Results ①The rate of treatment discontinuation of quetiapine and risperdal groups were 33.6% and 35.2%,respectively.The duration of treatment of quetiapine and risperdal groups were(9.49±3.83) and(9.52±3.84) months respectively.The duration to relapse of quetiapine and risperdal groups were(3.29±2.34) and(5.11±2.77) months,respectively.There were no significant differences in the rate of treatment discontinuation,the duration of treatment and the duration to relapse between two groups(P>0.05).②The response rates at the end of 2,6,12 months were 78.6%(103/131),86.2%(13/131) and 89.3%(117/131) in quetiapine group,and 82.4%(108/131),87.7%(115/131) and 85.5%(112/131) in risperdal group,respectively.The global efficacy of quetiapine was similar to that of risperdal(P>0.05).③Adverse effects: The rate of extrapyramidal side effects induced by risperdal,such as akathisia,muscle rigidity and tremor,was higer than that of quetiapine(X2=14.94,P<0.05).The rate of dizziness induced by quetiapine was higer than that of risperdal(X2=10.08,P<0.05).Conclusions Both quetiapine and risperdal are effective in the acute phase of first-episode schizophrenia as well as long-term treatment.The efficacy of quetiapine is similar to that of risperdal.Although there is significant difference in the adverse effects between quetiapine and risperdal.